Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
Business Of Biotech
00:00
The Importance of Synergizing Systems and Technologies
You mentioned how good Bontiabetics was with processes and sort of the mechanistic part of market presentation. And I assume that they were also pretty mature on the sort of technologies and systems continuum given their progress in the clinical front. So but I think that's often an afterthought like when you bring two companies together and you want to unify them quickly. There are going to be some winners, some losers, maybe some hybrid sort of activity. But what was your experience there and what do you anticipate moving forward in terms of meshing and I guess sort of synergizing the systems that make each company go? Yeah.
Transcript
Play full episode
